Of these, CC-16 has emerged as a possible mediator of lung function in COPD, where reduced CC-16 levels are associated with accelerated decline in lung function over time as well as COPD progression [11, 12]. The gene discussed is SCGB1A1; the disease is chronic obstructive pulmonary disease.